Dopamine transporter (DAT) single-photon emission computed tomography (SPECT) demonstrates early dopaminergic dysfunction and its association with cognitive impairment in PD-MCI patients by detecting dopaminergic nerve terminal density in the striatum. This evidence concerns the gene SLC6A3 and Cognitive impairment.